Introduction
============

Reproductive mode is subject to intense selective pressure and any modification will directly affect an organism\'s fitness. Thus, the transition between oviparity (egg-laying) and viviparity (live-bearing) is one of the most dramatic changes in the evolution of vertebrate animals. As a result of constraints on reproductive function, most vertebrate clades show a high phylogenetic conservatism in reproductive mode. For example, therian mammals represent only a single (albeit the best-known) origin of viviparity, whereas birds, alligators, and turtles exhibit only oviparity. By contrast, the evolutionary history of squamate reptiles (lizards and snakes) includes over 100 transitions from oviparity to viviparity, more than all other lineages of vertebrates combined ([@bib9]), with an extraordinary diversity of placental morphology and physiology ([@bib11]; [@bib8]; [@bib94]; [@bib99]). Squamates are therefore an ideal model system with which to explore the processes that shape the evolution of viviparity and placentation in vertebrates.

Viviparity and placentation in squamate reptiles have been the subject of extensive morphological and physiological studies (e.g., [@bib108]; [@bib8]; [@bib100]; [@bib96]; [@bib99]). These studies have described a continuum of placental complexity, ranging from simple placentae formed by the apposition of uterine and embryonic tissue (e.g., most *Eulamprus quoyii* group skinks; [@bib62]) to highly complex placentae characterized by extensive folding of the uterus associated with blood vessels and containing enlarged uterine and chorionic epithelial cells (e.g., some *Mabuya* group skinks; [@bib46]; [@bib79]; [@bib102]; [@bib10]). For the purposes of this discussion, we refer to these ends of the morphological complexity spectrum as "simple" and "complex," although we note these categories are an oversimplification of the true underlying diversity (see [@bib8]). Subsequent studies have quantified nutrient exchange across these different placental types and have concluded that very little maternal to embryonic transfer occurs via simple placentae, but substantial transfer occurs in species with more complex placentae. In one extreme, the embryos of the South American skink, *Mabuya bistrata* experience a 47,400% increase in dry mass ([@bib104]) compared with an average of a 25% decrease in dry mass of oviparous species ([@bib100]).

Although much is known about the morphological and physiological changes involved in reptilian pregnancy, there has been little examination of the genetic architecture that underlies them (for review, see [@bib64]). Multiple studies have used a targeted gene approach to assess the expression of genes involved with remodeling of embryonic and maternal tissue ([@bib4], [@bib5]; [@bib112]), increasing uterine blood supply to facilitate nutrient and gas exchange with the embryo ([@bib65]), modifying the maternal immune system to prevent rejection of embryos ([@bib74]; [@bib82]), and supplying nutrients to the embryo in addition to those provided in the yolk ([@bib6]).

Although these studies provided important information into genes critical to maintaining squamate reptile pregnancy, the candidate gene approach used in those studies is not adequate to profile the potentially thousands of genes that are regulated during pregnancy in squamate reptiles. Indeed, until recently, it has not been technically feasible to investigate the genetic controls of viviparity and placental development in nonmammalian vertebrates because the necessary baseline genomic data have not been available. However, recent technological advances (RNA-Seq; [@bib57]) provide the first opportunity to both identify and quantify almost all of the genes expressed in the reptilian uterus. The integration of transcriptomic data with existing morphological and physiological data now allows us to elucidate the genetic mechanisms that underlie reptilian pregnancy, which are subject to drastic change during evolutionary transitions between reproductive modes.

Here, we conduct the first comprehensive examination of gene regulation in a pregnant and nonpregnant viviparous lizard uterus using RNA-Seq. Using the viviparous Ocellated Skink, *Chalcides ocellatus* as a model system, we provide a near complete gene expression profile associated with maintaining pregnancy ([supplementary information 1](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1), [Supplementary Material](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1) online). *Chalcides ocellatus* is an ideal subject for this study because it possesses a relatively complex placenta with endometrial folds and histotrophic activity ([@bib26], [@bib24]; it is roughly in the middle of the continuum of simple to very complex placenta) and because partial gene expression data exist on *Chalcides chalcides*, a congener used in previous candidate gene analyses ([@bib74], [@bib75]; [@bib82]). We focus particularly on suites of genes associated with growth and remodeling of the uterus, the maternal immune system, transport across the placenta, and uterine metabolism because they are important functions of maintaining pregnancy and have also been the subject of mammalian, and to a lesser extent, squamate reptile gene expression analyses. We compare the gene expression profiles of the uterus of *C. ocellatus* with mammalian models to determine whether similar genetic mechanisms have evolved to maintain pregnancy mammals and reptiles. Similarities between reptiles and mammals in uterine gene expression would suggest convergent evolution of genetic mechanisms in response to similar natural selection pressures. On the other hand, significant differences in gene expression would be evidence that there are potentially many genetic pathways that permit the transition to viviparity (i.e., "many means to an end"). Both possibilities are inherently interesting because they allow us to interpret the general processes under which pregnancy has evolved in vertebrate animals.

Materials and Methods
=====================

Adult *C. ocellatus* individuals were purchased from a commercial dealer. Phylogenetic comparison of a 396-nt fragment of cytochrome b mitochondrial DNA (mtDNA) from these individuals with a comprehensive *Chalcides* mtDNA data set ([@bib14]) revealed them to be from Egyptian populations of *C. ocellatus ocellatus* (results not shown). The lizards were housed at Yale University in ∼40 l glass aquaria with a 12 h light/dark photoperiod, a 24--37 °C thermal gradient (during the day), free access to water, and fed crickets three times a week*.* From a euthanized pregnant female, we dissected out a uterine egg chamber, removed the embryonic tissues attached to the uterus, and stored the uterus in RNA-Later (Ambion). The developmental state of the embryo was ∼37 according to the normal development table of [@bib29]. For a sample of nonpregnant uterus, we obtained an additional uterus from a female that was isolated for 6 weeks postpartum. There is no record of sperm retention in *C. ocellatus*, and the uterus showed no signs of pregnancy.

Total RNA was extracted from the uterus using an RNeasy Mini Kit (Qiagen). cDNA library construction and sequencing was performed by the Yale Center for Genome Analysis. The Illumina Genome Analyzer was used to sequence 72-bp pair-end fragments of cDNA libraries from both the pregnant and the nonpregnant samples.

There is no sequenced complete genome for *C. ocellatus*; indeed, only one complete genome of any nonavian reptile is currently sequenced (*Anolis carolinensis*), and it shares a common ancestor with *C. ocellatus* approximately 175 Ma ([@bib13]). To facilitate identification of sequenced transcripts, we therefore used ABySS 1.2.4 to assemble individual raw Illumina reads into larger contigs that are more easily identified. We used the subtractive multiple-*k* method of [@bib97] and constructed multiple assemblies using a range of *k*-mer lengths (25, 29, 33, 37, 41, 45, 49, 53, 57, 61, 65, and 69). We then used CD-HIT-EST ([@bib53]) to remove redundant contigs and then removed contigs less than 100 bp ([table 1](#tbl1){ref-type="table"}).

To identify the contigs, we used BlastX with an *e* value of 10^−5^ to compare them with a database including 38 complete sequenced genomes of vertebrate animals (Ensembl build 61). We note that this methodology will not identify recently diverged paralogs and may therefore underestimate the true diversity of genes expressed in the uterus but that this is a potential problem for all transcriptomic studies and does not alter our broad conclusions. The raw Illumina data were filtered to remove any reads less than 30 bp. We then used the short-read aligner Bowtie 0.12.7 ([@bib52]) to align these filtered reads from both the nonpregnant and the pregnant uterine samples to a database composed of the identified contigs, allowing two nucleotide mismatches. Because of differing sequence quality between the forward and the reverse pair-end reads, we chose to only use the forward reads for alignment. Because both reads were sequenced from the same fragment, this should introduce little or no bias in the gene counts.

We assessed differential gene expression of normalized numbers of transcripts between the nonpregnant and the pregnant samples using the DEGseq ([@bib107]) R package. Preliminary analysis revealed that some genes are massively upregulated in the pregnant uterus (e.g., 497,141 reads of cathepsin L1 in the pregnant uterus compared with 917 reads in the nonpregnant; see Results and Discussion). Because the number of cDNA fragments sequenced is finite, we were concerned that several highly expressed genes were sequenced at the expense of others, thereby artificially lowering the apparent expression of other genes ([@bib81]). To try to mitigate this sequencing artifact, we used the trimmed mean of *M* values (TMM) method of [@bib81] in the edgeR R package ([@bib80]) to normalize the data and create an effective library size for both samples. We scaled both the pregnant and the nonpregnant libraries to "counts per 10^7^ reads" using the following formula:where the TMM estimated normalization factor is 0.698231 for the pregnant library and 1.0 for the nonpregnant library and the original library sizes of 20,060,751 and 23,120,916, respectively. We then estimated differential expression of each gene between the nonpregnant and the pregnant samples using the MA plot--based method with random sampling model (MARS; [@bib107]) in the DEGseq using a *P* value cutoff of 0.001 and a false discovery rate of 0.1%.

We used Gene Ontology (GO) analyses to broadly infer the biological function of the genes significantly regulated (as identified in the MARS differential expression analysis) in the uterine transcriptomes. We imported gene symbol lists of the significantly regulated genes in both the pregnant and the nonpregnant uteri into the Database for Annotation, Visualization, and Integrated Discovery (DAVID) functional GO annotation program and calculated GO terms corresponding to biological processes (BP-FAT). To more easily interpret the hundreds of individual GO biological functions inferred by DAVID, we aggregated similar processes to the following broad functional groups:Catabolism---processes that breakdown complex molecules. This group contains any GO biological processes that were explicitly catabolic or proteolytic.Cell death and differentiation---processes that regulate cellular proliferation, mitosis, and death.Cell morphogenesis and development---processes involved with cell organization, including localization, cytoskeleton maintenance, tissue development, and motility.Gene expression---processes that regulate transcription, translation, and posttranscriptional modification.Homeostasis and response to stimuli---processes involved with maintaining homeostasis or reaction to stimuli.Metabolism and energy---processes involved with the metabolism of macromolecules such as amino acids, lipids, nucleic acids, and proteins for the production of energy that are not explicitly catabolic (see above). This group also contains those mitochondrial processes involved in ATP production.Molecule biosynthesis---processes that result in the production of macromolecules.Signaling---processes involved with intracellular communication.Transport---processes that transport both organic and inorganic molecules both intracellularly and intercellularly.Other---those processes that do not naturally fit into any of the above categories.

We grouped individual GO biological processes into the above categories provided they were represented by at least 50 unique genes. We note that these categories are not necessarily mutually exclusive as, for example, those processes involved in catabolism are also metabolic. However, we chose to identify separately explicit catabolic functions given the substantial upregulation of proteolytic and hydrolytic enzymes in the pregnant uterus (see Results and Discussion).

Results and Discussion
======================

Our study is the first to survey the almost complete gene expression profile associated with maintaining pregnancy in a live-bearing reptile. Indeed, it is one of few studies that have used RNA-Seq to assess gene expression in any reptile ([@bib37]; [@bib85]; [@bib106]). Our transcript identification analysis positively identified 12,070,543 of 20,060,751 (60.2%) transcripts in the pregnant and 12,330,621 of 23,120,916 (53.8%) transcripts in the nonpregnant *C. ocellatus* uterine transcriptome ([s](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1)[upplementary i](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1)[nformation 1](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1), [Supplementary Material](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1) online). If we assume a minimum cutoff of ≥2 transcripts per million reads as our conservative criterion for calling a gene expressed, we identified 8,846 unique genes expressed in the pregnant and 8,881 unique genes expressed in the nonpregnant uteri, 8,296 (88%) of which are expressed in both the nonpregnant and the pregnant uterus. Our differential expression analysis using the MARS method in DEGseq identified a total of 3,903 upregulated and 2,709 downregulated genes in the pregnant *C. ocellatus* uterus, respectively. The 50 most upregulated and downregulated genes (as assessed by *z*-score) in the uterus of the pregnant *C. ocellatus* uterus, as well as specific genes discussed in the remainder of the paper, are provided in [tables 2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}.

###### 

Characteristics of Contigs Assembled by ABySS Using the Subtractive Multiple-*k* Method ([@bib97])

  ----------------------- ---------
  Number of Contigs       300,967
  Maximum contig length   15,179
  Mean contig length      530
  Median contig length    165
  N50                     1,454
  ----------------------- ---------

###### 

A Selection of Significantly Upregulated Genes in the Pregnant *Chalcides ocellatus* Uterus as Inferred by the MARS Differential Gene Expression Analysis of TMM Transformed Transcript Counts

  Gene Symbol   Gene Name                                            Pregnant Transcript Count (Raw)   Nonpregnant Transcript Count (Raw)   Pregnant Transcript Count (Transformed)   Nonpregnant Transcript Count (Transformed)   Log~2~-Fold Change   *Z*-Score   Expression Rank
  ------------- ---------------------------------------------------- --------------------------------- ------------------------------------ ----------------------------------------- -------------------------------------------- -------------------- ----------- -----------------
  ACTB          Actin, beta                                          95,506                            39,786                               133,776                                   55,728                                       1.3                  154.2       16
  AGTRAP        Angiotensin II receptor--associated protein          1,177                             657                                  840                                       284                                          1.6                  16.9        1,058
  ALDOA         Aldolase A                                           10,459                            9,017                                7,467                                     3,900                                        0.9                  33.7        384
  ALDOB         Aldolase B                                           7,194                             291                                  5,136                                     126                                          5.3                  74.4        94
  ALDOC         Aldolase C                                           275                               123                                  196                                       53                                           1.9                  9.3         1,991
  ANG           Angiogenin                                           14,189                            4,337                                10,130                                    1,876                                        2.4                  78.7        80
  ANGPT4        Angiopoietin 4                                       451                               199                                  322                                       86                                           1.9                  12.0        1,575
  ANXA4         Annexin A4                                           12,674                            3,524                                9,048                                     1,524                                        2.6                  76.8        87
  APOA1         Apolipoprotein A-I                                   102                               2                                    73                                        1                                            6.2                  8.9         2,090
  APOA2         Apolipoprotein A-II                                  1,123                             0                                    802                                       0                                            10.6                 23.4        720
  APOA4         Apolipoprotein A-IV                                  331                               109                                  236                                       47                                           2.3                  11.7        1,617
  APOE          Apolipoprotein E                                     8,568                             2,879                                6,117                                     1,245                                        2.3                  59.1        145
  APOM          Apolipoprotein M                                     34                                2                                    24                                        1                                            4.6                  5.0         3,188
  AQPP11        Aquaporin 11                                         123                               28                                   88                                        12                                           2.9                  8.0         2,279
  AQPP3         Aquaporin 3                                          859                               837                                  613                                       362                                          0.8                  8.1         2,266
  AQPP5         Aquaporin 5                                          2,391                             18                                   1,707                                     8                                            7.7                  41.0        279
  ARG2          Amino acid acetyltransferase                         16,563                            81                                   23,200                                    113                                          7.7                  128.0       22
  ATP1A1        ATPase, Na^+^/K^+^ transporting, alpha 1             54,438                            10,240                               38,865                                    4,429                                        3.1                  176.0       11
  BPI2          Bactericidal/permeability-increasing protein 2       17,327                            97                                   12,370                                    42                                           8.2                  107.9       40
  BTG1          B-cell translocation gene 1                          16,577                            1,535                                11,835                                    664                                          4.2                  107.9       41
  CA2           Carbonic anhydrase II                                7,873                             749                                  5,621                                     324                                          4.1                  74.1        95
  CAT           Catalase                                             41,302                            604                                  57,852                                    846                                          6.1                  211.2       8
  CDH1          Cadherin 1                                           12,711                            3,753                                9,075                                     1,623                                        2.5                  75.4        91
  CDH11         Cadherin 11                                          20,807                            634                                  14,855                                    274                                          5.8                  126.8       24
  CDH15         Cadherin 15                                          1,735                             1,214                                1,239                                     525                                          1.2                  17.2        1,037
  CDH2          Cadherin 2                                           685                               717                                  489                                       310                                          0.7                  6.4         2,732
  CDH24         Protocadherin 24                                     99                                60                                   71                                        26                                           1.4                  4.7         3,305
  CDH4          Cadherin 4                                           4,170                             21                                   2,977                                     9                                            8.4                  52.5        185
  CHY           Chymosin                                             12,199                            12                                   8,709                                     5                                            10.8                 76.2        88
  CKB           Creatine kinase                                      20,847                            3,963                                14,883                                    1,714                                        3.1                  108.6       38
  CLDN1         Claudin 1                                            9,577                             601                                  6,837                                     260                                          4.7                  84.4        67
  CLDN12        Claudin 12                                           214                               222                                  153                                       96                                           0.7                  3.6         3,732
  CLDN23        Claudin 23                                           92                                60                                   66                                        26                                           1.3                  4.2         3,478
  CLDN3         Claudin 3                                            2,806                             2,719                                2,003                                     1,176                                        0.8                  14.8        1,245
  CLDN4         Claudin 4                                            8,586                             4,014                                6,130                                     1,736                                        1.8                  51.0        197
  CLDN5         Claudin 5                                            557                               587                                  398                                       254                                          0.6                  5.7         2,963
  CLDN6         Claudin 6                                            3,666                             2,451                                2,617                                     1,060                                        1.3                  26.1        613
  CLDN7         Claudin 7                                            3,596                             1,716                                2,567                                     742                                          1.8                  32.6        417
  CLDN8         Claudin 8                                            5,015                             111                                  3,580                                     48                                           6.2                  62.1        135
  CO3           Cytochrome c oxidase subunit 3                       37,325                            14,477                               52,281                                    20,278                                       1.4                  102.2       48
  COL6A3        Collagen, type VI, alpha 3                           14,847                            1,170                                20,796                                    1,639                                        3.7                  116.0       28
  CPA2          Carboxypeptidase A2                                  18,052                            4,020                                25,286                                    5,631                                        2.2                  98.1        50
  CSTC          Cystatin C                                           18,365                            1,827                                13,111                                    790                                          4.1                  112.7       35
  CSTM          Cystatin 6/M/E                                       30,367                            95                                   21,680                                    41                                           9.0                  136.2       20
  CTSA          Cathepsin A                                          6,942                             1,022                                4,956                                     442                                          3.5                  65.8        119
  CTSB          Cathepsin B                                          17,222                            5,309                                12,295                                    2,296                                        2.4                  86.5        64
  CTSD          Cathepsin D                                          10,474                            7,033                                7,478                                     3,042                                        1.3                  43.9        253
  CTSE          Cathepsin E                                          67                                7                                    48                                        3                                            4.0                  6.8         2,630
  CTSF          Cathepsin F                                          1,269                             1,105                                906                                       478                                          0.9                  11.6        1,633
  CTSL          Cathepsin L1                                         497,141                           918                                  354,922                                   397                                          9.8                  523.9       1
  CTSV          Cathepsin V (cathepsin L2)                           106,855                           129                                  76,287                                    56                                           10.4                 232.0       6
  CTSZ          Cathepsin Z                                          65,117                            999                                  46,489                                    432                                          6.7                  221.5       7
  CYB           Cytochrome b                                         39,111                            14,696                               54,783                                    20,585                                       1.4                  107.3       44
  DDIT4         DNA damage--inducible transcript 4                   15,069                            569                                  10,758                                    246                                          5.5                  107.8       42
  DSG2          Desmoglein 2                                         2,002                             946                                  1,429                                     409                                          1.8                  24.5        676
  ENPP2         Ectonucleotide pyrophosphatase/phosphodiesterase 2   13,373                            60                                   9,547                                     26                                           8.5                  93.2        56
  EPAS1         Endothelial PAS domain protein 1                     41,345                            2,946                                29,517                                    1,274                                        4.5                  174.1       12
  FABP1         Fatty acid--binding protein 1                        14,898                            0                                    10,636                                    0                                            14.4                 60.2        140
  FABP2         Fatty acid--binding protein 2                        97                                2                                    69                                        1                                            6.1                  8.6         2,147
  FABP3         Fatty acid--binding protein 3                        2,247                             395                                  1,604                                     171                                          3.2                  36.2        340
  FABP4         Fatty acid--binding protein 4                        3,051                             523                                  2,178                                     226                                          3.3                  42.4        268
  FABP5         Fatty acid--binding protein 5                        1,198                             388                                  855                                       168                                          2.3                  22.4        765
  FABP7         Fatty acid--binding protein 7                        12,174                            2                                    8,691                                     1                                            13.1                 61.9        136
  FN1           Fibronectin protein                                  15,382                            2,046                                21,546                                    2,866                                        2.9                  106.9       45
  FTL           Ferritin, light polypeptide                          36,692                            10,208                               51,395                                    14,298                                       1.8                  126.0       25
  FUCA1         Fucosidase, alpha-L1                                 145,697                           220                                  104,017                                   95                                           10.1                 277.5       5
  FUCA2         Fucosidase, alpha-L2                                 129,789                           765                                  92,660                                    331                                          8.1                  296.6       4
  GAPDH         Glyceraldehyde-3-phosphate dehydrogenase             29,268                            15,408                               20,895                                    6,664                                        1.6                  87.8        62
  GGH           Gamma-glutamyl hydrolase                             12,615                            85                                   17,670                                    119                                          7.2                  113.8       33
  GLA           Galactosidase, alpha                                 16,970                            486                                  12,115                                    210                                          5.9                  114.5       32
  GLB1          Galactosidase, beta 1                                14,934                            513                                  10,662                                    222                                          5.6                  107.4       43
  GLUL          Glutamate--ammonia ligase (glutamine synthetase)     50,207                            3,729                                35,844                                    1613                                         4.5                  191.3       10
  GRN           Granulin                                             10,060                            1,385                                7,182                                     599                                          3.6                  80.0        74
  GSN           Gelsolin                                             19,199                            5,489                                13,707                                    2,374                                        2.5                  93.7        54
  GPX1          Glutathione peroxidase 1                             3,871                             1,307                                5,422                                     1,831                                        1.6                  36.4        337
  GPX3          Glutathione peroxidase 3                             2,969                             23                                   4,159                                     32                                           7.0                  55.6        161
  GPX4          Glutathione peroxidase 4                             2,996                             957                                  4,197                                     1,340                                        1.6                  33.2        396
  GPX5          Glutathione peroxidase 5                             1,484                             22                                   2,079                                     31                                           6.1                  40.0        287
  HEXA          Hexosaminidase A                                     196,426                           183                                  140,234                                   79                                           10.8                 305.3       3
  HEXB          Hexosaminidase B                                     15,870                            192                                  11,330                                    83                                           7.1                  108.3       39
  HMGCS2        3-Hydroxy-3-methylglutaryl-Coenzyme A synthase 2     9,362                             55                                   6,684                                     24                                           8.1                  79.7        76
  HYAL3         Hyaluronoglucosaminidase 1                           17,923                            46                                   12,796                                    20                                           9.3                  102.8       47
  HYAL4         Hyaluronoglucosaminidase 3                           12,479                            0                                    8,909                                     0                                            14.1                 56.5        157
  IFI30         Interferon gamma--inducible protein 30/GILT          11,020                            138                                  15,436                                    193                                          6.3                  108.8       37
  IL20RB        Interleukin 20 receptor beta                         8,497                             261                                  6,066                                     113                                          5.7                  81.0        69
  KRT18         Keratin 18                                           19,527                            3,222                                27,352                                    4,513                                        2.6                  113.5       34
  KRT8          Keratin 8                                            20,650                            3,619                                28,925                                    5,069                                        2.5                  114.5       31
  LDHA          Lactate dehydrogenase A                              10,376                            1,447                                7,408                                     626                                          3.6                  81.1        68
  LGMN          Legumain                                             57,922                            430                                  41,352                                    186                                          7.8                  201.3       9
  MDH1          Malate dehydrogenase 1                               8,071                             3,725                                5,762                                     1,611                                        1.8                  49.7        207
  MDH2          Malate dehydrogenase 2                               5,076                             3,831                                3,624                                     1,657                                        1.1                  27.4        572
  NAGA          Alpha-*N*-acetylgalactosaminidase                    25,652                            354                                  18,314                                    153                                          6.9                  138.4       19
  NDRG1         *N*-myc downstream--regulated 1                      26,922                            1,595                                19,220                                    690                                          4.8                  142.0       18
  NEU1          Sialidase 1                                          29,234                            76                                   20,871                                    33                                           9.3                  131.4       21
  NFAT5         Nuclear factor of activated T-cells 5                10,795                            785                                  15,121                                    1,100                                        3.8                  100.0       49
  OVGP1         Oviductal glycoprotein 1, 120 kDa                    29,231                            217                                  40,944                                    304                                          7.1                  174.0       13
  PCK2          Phosphoenolpyruvate carboxykinase 2                  8,634                             511                                  6,164                                     221                                          4.8                  80.4        73
  PGAM1         Phosphoglycerate mutase 1                            11,543                            2,573                                8,241                                     1,113                                        2.9                  77.9        83
  PKM2          Pyruvate kinase, isozymes M1/M2                      25,858                            6,134                                18,461                                    2,653                                        2.8                  114.8       30
  PLA2G1B       Phospholipase A2, group IB                           22,787                            187                                  16,268                                    81                                           7.6                  127.0       23
  PPIB          Peptidyl-prolyl *cis*-*trans*-isomerase B            16,423                            2,048                                23,004                                    2,869                                        3.0                  112.1       36
  PRCP          Prolylcarboxypeptidase (angiotensinase C)            2,944                             173                                  2,102                                     75                                           4.8                  47.0        229
  PRSS1         Protease, serine, 1                                  2,681                             0                                    1,914                                     0                                            11.9                 32.4        420
  PRSS12        Protease, serine, 12                                 1,290                             49                                   921                                       21                                           5.5                  31.5        443
  PRSS16        Protease, serine, 16                                 90,516                            9                                    64,622                                    4                                            14.0                 154.5       15
  PRSS2         Protease, serine, 2                                  148,046                           2                                    105,694                                   1                                            16.7                 147.5       17
  PRSS27        Protease, serine, 27                                 19,852                            1,096                                14,173                                    474                                          4.9                  122.3       26
  PRSS3         Protease, serine, 3                                  161,271                           5                                    115,136                                   2                                            15.8                 169.8       14
  PRSS33        Protease, serine, 33                                 994                               60                                   710                                       26                                           4.8                  27.3        578
  PRSS36        Protease, serine, 36                                 466                               12                                   333                                       5                                            6.1                  19.0        935
  PRSS8         Protease, serine, 8                                  11,814                            400                                  8,434                                     173                                          5.6                  95.5        52
  REN           Renin                                                15,355                            32                                   10,962                                    14                                           9.6                  93.3        55
  SLC15A1       Solute carrier family 15, member 1                   12,659                            22                                   17,732                                    31                                           9.2                  103.2       46
  SPINT1        Serine peptidase inhibitor, Kunitz type 1            10,400                            1,020                                7,425                                     441                                          4.1                  84.9        66
  SPINT2        Serine protease inhibitor, Kunitz type 2             14,494                            4,573                                10,348                                    1,978                                        2.4                  78.7        81
  TFPI2         Tissue factor pathway inhibitor 2                    17,908                            393                                  12,785                                    170                                          6.2                  117.3       27
  TPP1          Polynucleotide 3′-phosphatase                        162,913                           2,062                                116,308                                   892                                          7.0                  347.8       2
  VEGFA         Vascular endothelial growth factor A                 3,348                             1,727                                2,390                                     747                                          1.7                  30.1        495
  WSB1          WD repeat and SOCS box--containing 1                 14,527                            1,088                                20,348                                    1,524                                        3.7                  115.6       29

N[OTE.]{.smallcaps}---Only the top 50 most upregulated genes (as assessed by *z*-score), and those genes discussed in the text, are shown. The expression rank represents the order of expression in the entire upregulated transcriptome from highest to lowest (e.g., a rank of 1 is the highest change in expression). Complete results for the MARS analysis are provided in [supplementary information 1](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1) ([Supplementary Material](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1) online).

###### 

A Selection of Significantly Downregulated Genes in the Pregnant *Chalcides ocellatus* Uterus as Inferred by the MARS Differential Gene Expression Analysis of TMM Transformed Transcript Counts

  Gene Symbol   Gene Name                                                      Pregnant Transcript Count (Raw)   Nonpregnant Transcript Count (Raw)   Pregnant Transcript Count (Transformed)   Nonpregnant Transcript Count (Transformed)   Log~2~-Fold Change   *Z*-Score   Expression Rank
  ------------- -------------------------------------------------------------- --------------------------------- ------------------------------------ ----------------------------------------- -------------------------------------------- -------------------- ----------- -----------------
  ACTA2         Actin, alpha 2                                                 1,340                             7,007                                1,877                                     16,201                                       −2.4                 −64.8       19
  AHNAK         AHNAK nucleoprotein                                            6,465                             15,345                               9,056                                     35,479                                       −1.2                 −61.0       23
  BTF3          Basic transcription factor 3                                   3,393                             9,969                                4,753                                     23,049                                       −1.6                 −58.1       28
  C3            Complement component 3                                         2,256                             10,334                               3,160                                     23,893                                       −2.2                 −74.8       9
  CALD1         Caldesmon 1                                                    9,97                              5,162                                1,397                                     11,935                                       −2.4                 −55.4       31
  CD74          CD74 molecule                                                  503                               4,806                                705                                       11,112                                       −3.3                 −62.9       21
  CDH13         Cadherin 13                                                    48                                105                                  67                                        243                                          −1.1                 −4.7        2164
  CDH5          Cadherin 5                                                     40                                246                                  56                                        569                                          −2.6                 −12.8       686
  CNN1          Calponin 1                                                     612                               4,810                                857                                       11,121                                       −3.0                 −60.4       25
  COL12A1       Collagen, type XII, alpha 1                                    306                               6,613                                429                                       15,290                                       −4.4                 −82.0       6
  CXCL14        Chemokine (C-X-C motif) ligand 14                              56                                3,551                                78                                        8,210                                        −6.0                 −62.0       22
  DCN           Decorin                                                        361                               3,191                                506                                       7,378                                        −3.1                 −50.5       41
  DDX50         DEAD (Asp-Glu-Ala-Asp) box polypeptide 50                      8,260                             23,789                               11,570                                    55,002                                       −1.5                 −88.6       4
  DES           Desmin                                                         1,883                             9,420                                2,638                                     21,780                                       −2.3                 −73.9       11
  EFEMP1        EGF-containing fibulin-like extracellular matrix protein 1     448                               3,065                                628                                       7,087                                        −2.8                 −46.5       48
  ESR1          Estrogen receptor 1                                            499                               7,745                                699                                       17,907                                       −4.0                 −86.0       5
  GAS1          1,3-Beta-glucanosyltransferase GAS1                            1304                              4,980                                1,827                                     11,514                                       −1.9                 −47.8       42
  GPI           Glucose-6-phosphate isomerase                                  6,118                             14,803                               8,570                                     34,226                                       −1.3                 −61.0       24
  GPR124        G protein--coupled receptor 124                                228                               4,267                                319                                       9,866                                        −4.2                 −65.1       18
  HMGB1         High-mobility group 1                                          856                               4,490                                1,199                                     10,381                                       −2.4                 −51.9       39
  HSP90AB1      Heat shock protein 90 kDa alpha, class B member 1              6,564                             15,181                               9,194                                     35,100                                       −1.2                 −59.3       27
  IFITM3        Interferon-induced transmembrane protein 3                     568                               3,435                                796                                       7,942                                        −2.6                 −47.6       44
  IGFBP5        Insulin-like growth factor--binding protein 5                  289                               5,002                                405                                       11,565                                       −4.1                 −69.9       12
  LGR5          Leucine-rich repeat-containing G protein--coupled receptor 5   436                               8,664                                611                                       20,032                                       −4.3                 −93.2       1
  MEIS1         Meis homeobox 1                                                316                               2,680                                443                                       6,196                                        −3.1                 −45.9       49
  MHCIA         MHC Class IA                                                   1,651                             11,834                               2,313                                     27,361                                       −2.8                 −92.6       2
  MHCIIA        MHC Class IIA                                                  637                               5,550                                892                                       12,832                                       −3.1                 −66.4       17
  MHCIIB        MHC Class IIB                                                  835                               4,703                                1,170                                     10,874                                       −2.5                 −54.4       34
  MYH11         Myosin, heavy chain 11                                         1,940                             9,598                                2,717                                     22,191                                       −2.3                 −74.3       10
  PCLP1         Podocalyxin-like protein 1                                     965                               6,741                                1,352                                     15,586                                       −2.8                 −69.4       13
  PDLIM4        PDZ and LIM domain 4                                           364                               6,474                                510                                       14,968                                       −4.2                 −79.8       8
  PGR           Progesterone receptor                                          283                               2,345                                396                                       5,422                                        −3.1                 −42.7       61
  PTGIS         Prostaglandin I2 (prostacyclin) synthase                       131                               1,580                                183                                       3,653                                        −3.6                 −37.6       93
  RPL10A        60S ribosomal protein L10A                                     5,856                             17,979                               8,203                                     41,569                                       −1.6                 −80.4       7
  RPL14         50S ribosomal protein L14                                      3,239                             8,857                                4,537                                     20,478                                       −1.5                 −52.1       38
  RPL17         50S ribosomal protein L17                                      6,268                             13,974                               8,780                                     32,309                                       −1.2                 −54.9       32
  RPL18A        50S ribosomal protein L18A                                     2,656                             10,063                               3,720                                     23,267                                       −1.9                 −67.7       16
  RPL19         50S ribosomal protein L19                                      4,645                             10,270                               6,506                                     23,745                                       −1.1                 −46.6       47
  RPL27A        50S ribosomal protein L27A                                     2,685                             8,070                                3,761                                     18,659                                       −1.6                 −53.1       35
  RPL32         60S ribosomal protein L32                                      3,513                             8,440                                4,921                                     19,514                                       −1.3                 −45.7       50
  RPL37         60S ribosomal protein L37A                                     2,163                             8,028                                3,030                                     18,561                                       −1.9                 −59.9       26
  RPL4          60S ribosomal protein L4                                       8,509                             19,769                               11,919                                    45,708                                       −1.2                 −67.9       15
  RPLP2         60S ribosomal protein LP2                                      2,023                             6,650                                2,834                                     15,375                                       −1.7                 −51.0       40
  RPS13         40S ribosomal protein S13                                      3,213                             9,151                                4,500                                     21,158                                       −1.5                 −54.5       33
  RPS2          40S ribosomal protein S2                                       12,945                            22,719                               18,132                                    52,528                                       −0.8                 −52.1       37
  RPS23         40S ribosomal protein S23                                      2,612                             7,930                                3,659                                     18,335                                       −1.6                 −53.0       36
  RPS7          40S ribosomal protein S7                                       2,504                             13,326                               3,507                                     30,811                                       −2.4                 −89.9       3
  RPS8          40S ribosomal protein S8                                       3,464                             11,054                               4,852                                     25,558                                       −1.7                 −64.6       20
  RPS9          40S ribosomal protein S9                                       5,272                             11,266                               7,385                                     26,048                                       −1.1                 −47.2       45
  SLC6A6        Solute carrier family 6, member A6                             845                               4,998                                1,184                                     11,556                                       −2.6                 −57.0       29
  SLIT2         Slit homolog 2                                                 276                               2,727                                387                                       6,305                                        −3.3                 −47.7       43
  SOX7          SRY (sex-determining region Y)-box 7                           318                               2,784                                445                                       6,437                                        −3.1                 −47.1       46
  TNS3          Tensin 3                                                       675                               6,013                                945                                       13,903                                       −3.2                 −69.4       14
  TPBG          Trophoblast glycoprotein                                       271                               3,464                                380                                       8,009                                        −3.7                 −56.1       30

N[OTE.]{.smallcaps}---Only the top 50 most downregulated genes (as assessed by *z*-score), and those genes discussed in the text, are shown. The expression rank represents the order of expression in the entire nonpregnant uterine transcriptome from highest to lowest (e.g., a rank of 1 is the highest change in expression). Complete results for the MARS analysis are provided in [supplementary information 1](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1) ([Supplementary Material](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1) online).

It is notable that many of the genes downregulated in the pregnant *C. ocellatus* uterus are genes involved with basic cellular housekeeping processes (e.g., ribosomal subunit proteins, desmin, myosin; [table 3](#tbl3){ref-type="table"}), which could indicate that the TMM normalization was inadequate and that these genes were undersampled. However, if these data were improperly normalized, then properly normalizing them would only increase the relative number of highly expressed transcripts in the pregnant uterus ([table 2](#tbl2){ref-type="table"}) and therefore does not severely impact our conclusions. We also emphasize that, given the lack of comparative genomic resources, we were unable to identify almost half of the sequenced transcripts and we have likely undersampled particularly quickly evolving genes---a challenge inherent in any RNA-Seq study of an organism with no closely related sequenced genome.

Most of the genes expressed in the pregnant uterus are also expressed in the nonpregnant uterus, which suggests that the morphological and physiological processes that maintain reptilian pregnancy are mostly a function of differential regulation of genes continually expressed in the uterus rather than the new expression of unique genes. If a similar pattern exists in the expression profiles of other oviparous and viviparous squamate reptiles, it would suggest that the evolutionary transition to viviparity is relatively "easy" given that the necessary genes are already expressed in the uterus when not gravid/pregnant and only become modulated in their expression level rather reprogrammed.

The GO biological function analysis revealed that *C. ocellatus* pregnancy is associated with upregulation of genes involved with catabolism, cell death and differentiation, homeostasis and response to stimuli, cellular signaling, and transport are upregulated in the pregnant uterus. By contrast, the nonpregnant uterus is dominated by genes that regulate cell morphogenesis and development, gene expression, and other processes.

Given the impracticality of examining the expression and function of each gene, we limit our discussion primarily to suites of genes that are associated with the biological functions that are apparently critical to maintaining pregnancy, including growth and remodeling of the uterus, nutrient transport across the placenta, and uterine metabolism and histotrophy. We also focus on the regulation of the maternal immune system and estrogen and progesterone activity, given their importance in maintaining mammalian pregnancy. We particularly focus on the most highly upregulated and downregulated genes identified by the MARS analysis and genes that have been assessed previously in squamate reptiles ([table 4](#tbl4){ref-type="table"}). Unless otherwise stated, we limit our discussion to only genes that are significantly upregulated or downregulated (*P* ≤ 0.001) according to our MARS differential expression analysis. The entire results of the differential expression analysis for all genes are provided in the [s](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1)[upplementary i](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1)[nformation](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1)[1](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1) ([Supplementary Material](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1) online).

###### 

Genes Whose Regulation Has Been Assessed Previously in Squamate Reptiles and Comparison with *Chalcides ocellatus*

  Gene                                                            Species                 Regulatory Activity during Pregnancy   Reference
  --------------------------------------------------------------- ----------------------- -------------------------------------- ------------
  Desmoglein 2 (DSG2)                                             *Chalcides ocellatus*   Increase                               This study
  *Lerista bougainvillii*[a](#tblfn1){ref-type="table-fn"}        No change               [@bib7]                                
  *Pseudemoia entrecasteauxii*                                    Decrease                [@bib7]                                
  *Pseudemoia spenceri*                                           Decrease                [@bib7]                                
  *Saiphos equalis*[a](#tblfn1){ref-type="table-fn"}              No change               [@bib7]                                
  Occludin (OCLN)                                                 *C. ocellatus*          No change                              This study
  *Eulamprus tympanum*                                            Absent                  [@bib4]                                
  *P. entrecasteauxii*                                            Absent                  [@bib4]                                
  *P. spenceri*                                                   Increase                [@bib4]                                
  *S. equalis*^a^                                                 Increase                [@bib4]                                
  Claudin 5 (CLDN5)                                               *C. ocellatus*          Increase                               This study
  *E. tympanum*                                                   Present                 [@bib5]                                
  *L. bougainvillii*[a](#tblfn1){ref-type="table-fn"}             Present                 [@bib5]                                
  *P. entrecasteauxii*                                            Present                 [@bib5]                                
  *P. spenceri*                                                   Present                 [@bib5]                                
  *S. equalis*[a](#tblfn1){ref-type="table-fn"}                   Present                 [@bib5]                                
  Cadherin (CDH)[b](#tblfn2){ref-type="table-fn"}                 *C. ocellatus*          Varied, but mostly increase            This study
  *L. bougainvillii*[a](#tblfn1){ref-type="table-fn"}             Decrease                [@bib112]                              
  *Niveoscincus metallicus*                                       Decrease                [@bib112]                              
  *Niveoscincus ocellatus*                                        Decrease                [@bib112]                              
  Vascular endothelial growth factor A (VEGFA)                    *C. ocellatus*          Increase                               This study
  *E. tympanum*                                                   Present                 [@bib61]                               
  *N. metallicus*                                                 Present                 [@bib61]                               
  *P. entrecasteauxii*                                            Present                 [@bib61]                               
  *S. equalis*[a](#tblfn1){ref-type="table-fn"}                   Increase                [@bib61]                               
  Interleukin 1A (IL1A)                                           *C. ocellatus*          Absent                                 This study
  *Chalcides chalcides*                                           Present                 [@bib74]                               
  *Zootoca (Lacerta) vivipara*[a](#tblfn1){ref-type="table-fn"}   Present                 [@bib76]                               
  Interleukin 1B (IL1B)                                           *C. ocellatus*          Absent                                 This study
  *C. chalcides*                                                  Present                 [@bib74]                               
  *Z. vivipara*[b](#tblfn2){ref-type="table-fn"}                  Present                 [@bib76]                               

N[OTE.]{.smallcaps}---Gene expression is identified as "present" if expression was inferred, but levels were not quantified between pregnant and nonpregnant individuals. Gene expression is identified as "no change" if expression was quantified, but there is no change in expression between pregnant and nonpregnant individuals.

Reproductively bimodal species. Only data for the viviparous individuals are presented.

Nonspecific "pan-cadherin" antibody used.

Growth and Remodeling of the Uterus
-----------------------------------

The increasing demands of the growing embryo, including gas exchange, nutrition, and uterine space, require both fundamental destruction and growth of uterine tissue to both increase the size of the uterus and maximize the surface area of the maternal--embryonic interface. Genes likely involved in these remodeling process are some of the most highly upregulated in the pregnant *C. ocellatus* uterus ([table 2](#tbl2){ref-type="table"}) and include cytoskeletal elements (e.g., β-actin and keratins) and gelsolin (a powerful actin regulator), genes that promote (e.g., N-myc downstream regulated 1, Granulin) and inhibit (e.g., B-cell translocation gene 1, DNA damage--inducible transcript four) cell proliferation, and hyaluronoglucosaminidases 3 and 4, that break down the extracellular matrix.

Although there are potentially hundreds or thousands of genes involved in the uterine remodeling process, we focus on the proteolytic enzymes because they are massively upregulated and have been the subjects of multiple studies of mammalian pregnancy. We also evaluate expression of the highly upregulated cell adhesion and angiogenic genes because they have been subject to previous studies in squamate reptiles ([@bib4], [@bib5], [@bib7]; [@bib61]; [@bib112]) and therefore provide a rare opportunity to assess the diversity of molecular mechanisms involved in reptilian pregnancy.

### Proteases

Because the close apposition of maternal and fetal tissue facilitates gas and nutrient exchange, uterine and placental tissues are remodeled to minimize this distance, regardless of whether the placental type is epitheliochorial, endothelialchorial, or hemochorial ([@bib31]). The destruction of this tissue is achieved, in part, via the actions of both cysteine and serine proteases ([@bib84]). Perhaps the most striking gene expression upregulation in the pregnant *C. ocellatus* uterine transcriptome is the enormous upregulation of cysteine and serine proteases. Cathepsins (CTS) are lysosomal cysteine proteases that degrade extracellular matrix and catabolize intracellular proteins ([@bib50]). Cathepsins make up over 8% of the entire upregulated transcriptome, with CTSL alone representing 5% of the transcriptome. The serine proteases PRSS2 (trypsin) and PRSS3 (mesotrypsin) have the highest log~2~-fold changes of all the upregulated genes (16.7 and 15.5, respectively; [table 2](#tbl2){ref-type="table"}). Taken together with other highly upregulated proteases such as legumain (LGMN) and tripeptidyl peptidase I (TPP1), these results reveal that the breakdown of tissue is one of the most active physiological processes in the *C. ocellatus* pregnant uterus.

Although the roles of cathepsins, especially CTSB and CTSL, in uterine remodeling has been elucidated in several mammal species (e.g., [@bib2]; [@bib30]; [@bib88], [@bib89]; [@bib101]), comparison of cathepsin expression between *C. ocellatus* lizards and pigs is most instructive because both possess an epitheliochorial placenta. In pigs, CTSB and CTSL are expressed in both uterine and chorionic epithelia, and this expression increases as pregnancy progresses ([@bib89]). Both CTSB and CTSL are upregulated in the pregnant *C. ocellatus* uterus, CTSL being the most abundant transcript in the transcriptome. Although we cannot localize expression of these genes to a specific region of the uterus, we nonetheless speculate that, as in mammals, these genes may have a primary role in degrading uterine tissue during the remodeling process in the *C. ocellatus* uterus.

Placental remodeling is an interplay between proteases and their inhibitors ([@bib2]; [@bib84]; [@bib88], [@bib87], [@bib89]), especially the reciprocal actions of cathepsins and their inhibitors, cystatins (CST). Cystatin C (CSTC) is a powerful inhibitor of cathepsins L and B and is highly upregulated in *C. ocellatus*. CTSL and two other lysosomal cysteine proteases, CTSV (also called CTSL2) and LGMN, are also inhibited by cystatin M/E (also called cystatin 6), a very highly upregulated gene in the pregnant *C. ocellatus* transcriptome. Moreover, multiple serine protease inhibitors, including tissue factor pathway inhibitor 2 (TFPI2), serine peptidase inhibitor, Kunitz types 1 and 2 (SPINT1 and 2), are significantly upregulated, thereby suggesting active regulation of serine protease activity. Thus, there is a clear pattern of protease expression and concomitant regulation by their inhibitors. Moreover, the genes likely responsible for these processes are identical to those used by mammals.

### Cell Adhesion

Remodeling of the uterus throughout pregnancy requires the growth and movement of the closely apposed maternal and embryonic surface epithelial cells and presumably the molecules that permit adhesion of these cells to one another. These cellular adhesion proteins, including those critical to the development of desmosomes, tight junctions, and adherens junctions, are some of the few proteins extensively studied in squamate reptiles (Australian skinks; [@bib4], [@bib5], [@bib7]; [@bib112]) and therefore provide a rare opportunity to assess gene expression differences amongst multiple species of viviparous reptiles ([table 4](#tbl4){ref-type="table"}).

Desmoglelin 2 (DSG2) is a protein involved in the formation of desmosomes and its expression has been evaluated in the uteri of four scincid lizards representing the extremes of placental development ([@bib7]). DSG2 expression is not different in pregnant and nonpregnant females in two species with simple placentae (*Lerista bougainvillii* and *Saiphos equalis*) but is lower during pregnancy in two species with complex placentae (*Pseudemoia entrecasteauxii* and *Pseudemoia spenceri*), which suggests that a decrease in desmosome number may allow for easier deformation and remodeling of the uterus. In contrast, our transcriptome results demonstrate a statistically significant increase in DSG2 expression in the uterus of pregnant *C. ocellatus* and in the absence of corroborating morphological data, presumably an increasing number of desmosomes.

In addition to simple cell adhesion, tight junctions regulate paracellular transport by controlling the permeability of the interstitial space between adjacent cells to molecules of specific sizes. Occludin (OCLN) and claudins (CLDN) are the dominant proteins in tight junctions. OCLN expression increases as pregnancy progresses in the uteri of two viviparous species of skinks with complex placentation (*P. entrecasteauxii* and *P. spenceri*), suggesting decreased paracellular permeability with compensation by transcellular transport ([@bib4]). OCLN expression was not detected in two species with simple placentae (*L. bougainvillii* and *S. equalis*; [@bib4]). Similarly, our transcriptomic analysis finds no significant difference in OCLN expression between nonpregnant and pregnant *C. ocellatus* females (*P* = 0.187), although this species has a more complex placenta. CLDN5 is expressed over the entire surface of the uterine epithelial cell in early pregnancy in four viviparous skink species but becomes localized at the tight junctions, suggesting an increased role of the tight junctions in limiting paracellular transport ([@bib5]). As no study has examined tight junction distribution in *C. ocellatus*, we cannot directly compare our results with [@bib5], but we do find significant upregulation of nine claudin loci, including CLDN1, 3--8, 12, and 23, suggesting that they have an important role in maintaining pregnancy in *C. ocellatus*.

Cadherins (CDH) are a family of proteins that are components of adherens junctions between adjacent cells. Cadherin expression is high near ovulation, as revealed using an antibody that labels all cadherins but significantly decreases as pregnancy progresses and is absent in late pregnancy in three species of Australian skinks ([@bib112]). Thus, decreasing cadherin expression, and therefore few adherens junctions, is speculated to allow the uterus to expand to accommodate the growing embryo ([@bib112]). In *C. ocellatus*, we detected a far more complicated expression profile of cadherins with significant upregulation of CDH1 (epithelial cadherin), 2, 4, 11, 15, 22, and 24 and downregulation of CDH5 and 13. This indicates that, unlike the three Australian skinks studied to date, adherens junctions actually proliferate in *C. ocellatus* during pregnancy and apparently do not inhibit uterine growth.

Our transcriptomic analyses reveal some significant differences between our study and previous studies of cell adhesion molecules in the uteri of viviparous skinks. These differing results could be due to the higher resolution of gene expression possible with transcript sequencing as opposed to immunological assays or western blots used in previous studies ([@bib4], [@bib5], [@bib7]; [@bib112]). However, rather than any methodological problem, a much more plausible explanation for the difference in uterine cell adhesion gene expression is that the study organisms represent ancient independent derivations of viviparity. Although also a skink, *C. ocellatus* and Australian lygosomine skinks share a common ancestor approximately 95 Ma ([@bib12], [@bib13]), about the same age as the common ancestor of primates, ungulates, carnivores, and bats ([@bib66]). It is therefore reasonable to hypothesize that these two skink lineages evolved different molecular processes and suggests that there is a diversity of genetic processes that act to maintain pregnancy within viviparous squamate reptiles.

### Angiogenesis and Vascular Physiology

As the embryo matures, its growing oxygen demand is accommodated by increasing placental vascularization ([@bib40]; [@bib58]; [@bib61]; [@bib63]; [@bib70]; [@bib71]). Like mammals, increasing expression of vascular endothelial growth factor A (VEGFA) in pregnant squamate reptiles is correlated with vascular growth in the uterus ([@bib61]). VEGFA is also significantly upregulated in the uterus of pregnant *C. ocellatus*. VEGFA is upregulated in addition to a suite of other genes with angiogenic properties. Most notable are the endothelial PAS domain protein 1 (EPAS1) and hypoxia-inducible factor 1α (HIF1A) genes that activate VEGF expression in response to hypoxic conditions ([@bib32]; [@bib77]; [@bib98]); interleukin 20 receptor β (IL20RB), an inducer of endothelial cell proliferation ([@bib33]; [@bib44]); angiogenin (ANG) and angiopoietin 4 (ANGPT4), and general cell proliferation genes with angiogenic properties such as ENPP2/Autotaxin. As in remodeling the structure of the uterus, proteolytic enzymes such as cathepsins are also associated with angiogenesis ([@bib48]).

In addition to genes that promote the development of blood vessels, several genes that control blood physiology are highly expressed in the *C. ocellatus* pregnant uterus. Prostacyclin (PTGIS), a vasodilator, is downregulated. Renin, a part of the renin--angiotensin system (RAS) that regulates blood pressure, is highly upregulated suggesting intense vasoconstriction of the uterine vasculature and consequently high blood pressure (perhaps facilitating the diffusion of oxygen and nutrients to the embryo across the placenta). Renin is expressed in the uteroplacental tissues of mammals where it participates in a local RAS ([@bib23]; [@bib69]; [@bib103]) that may also stimulate cell proliferation and angiogenesis ([@bib41]). However, renin does not directly increase blood pressure but rather converts angiotensinogen (AGT) to angiotensin I, which is then converted to the much more potent vasoconstrictor angiotensinogen II via action of angiotesin-converting enzyme (ACE). Angiotensinogen (AGT) is not significantly regulated in the pregnant *C. ocellatus* uterus, and we found no expression of ACE. Moreover, prolylcarboxypeptidase/angiotensinase C (PRCP) and angiotensin II receptor--associated protein (AGTRAP), two inhibitors of angiotensin II, are upregulated and therefore suggest that blood pressure is locally regulated by the expression of vasoconstrictors and dilators.

Regulation of the Maternal Innate Immune System
-----------------------------------------------

The embryo is an allograft of both maternal and paternal tissue and is therefore at risk of attack by the maternal immune system. As such, a variety of mechanisms that "hide" the embryo have evolved in mammals by downregulating elements of the maternal immune system ([@bib59]). This immune response is expected to be much higher in mammals with invasive placentation because the maternal epithelia are breached. With a single possible exception (*Trachylepis* \[*Mabuya*\] *ivensii*; [@bib10]), all viviparous squamate reptiles studied to date, including *C. ocellatus*, possess an epitheliochorial placenta with no breaching of the maternal epithelia. Nonetheless, as pregnancy progresses in squamate reptiles, the remnants of the ancestral shell membrane commonly disintegrate, thereby creating direct contact between the embryonic and the maternal epithelia ([@bib8]). Although the epithelia remain intact, studies of the mammalian epitheliochorial placentae demonstrate adaptations to hide from the maternal immune system ([@bib59]) by regulating the maternal innate immune system and embryonic major histocompatability (MHC) loci.

The innate immune system comprises the general mechanisms by which the body defends against infection in a nonspecific manner. Its components consist of leukocytes (e.g., macrophages, natural killer cells), general antimicrobial proteins (e.g., bactericidal/permeability-increasing protein 2), and molecules that promote inflammation (e.g., cytokines, chemokines). It differs from the adaptive immune system that recognizes and remembers specific pathogens and thereby provides long-term immunity. Inflammation is an innate immune response critical to fighting infection, but excessive uterine inflammation may also lead to spontaneous abortion ([@bib17]). Therefore, regulation of the proinflammatory and anti-inflammatory molecules in the pregnant uterus is essential to the maintenance of pregnancy while maintaining the maternal immune response to pathogens ([@bib105]). Inflammation is regulated by a suite of genes, many of them cytokines---molecules that initiate cascades of intracellular signaling that are particularly active in the innate immune system. In squamate reptiles, the interleukin 1 cytokine system has received particular attention. IL1A and IL1B, two proinflammatory cytokines that also initiate immune response and regulate cellular growth and differentiation, are expressed in the uterine epithelia of *C. chalcides*, a close relative of *C. ocellatus*, and this expression continues throughout pregnancy ([@bib74], [@bib76]; [@bib72]; [@bib82]; [@bib73]). Thus, it was assumed that IL1A and IL1B expression was involved in the maintenance of pregnancy in both *C. chalcides* and mammals.

Surprisingly, our transcriptomic analysis reveals no expression of either IL1A or IL1B in both pregnant and nonpregnant *C. ocellatus* uteri and only low (but significant) upregulation of an interleukin 1 receptor (IL1R1). If IL1R1 expression indicates IL1 activity, we cannot locate the source of transcripts, and the lack of IL1A or IL1B expression in the uterus *C. ocellatus* starkly contrasts with that detected in *C. chalcides*. A potential explanation for these conflicting results could be that we were unable to identify IL1A and IL1B transcripts using our sequence identification strategy. That is, IL1A and IL1B may evolve quickly enough that the *Chalcides* transcripts of these genes cannot be reliably aligned to those in our reference genomes. An alternate explanation is that uterine IL1 expression was lost in the evolutionary history of the lineage leading to extant *C. ocellatus*. However, *C. chalcides* and *C. ocellatus* share a common ancestor only ∼10.5 Ma ([@bib14]); that uterine expression of IL1 is also detected in *Zootoca* (*Lacerta*) *vivipara* ([@bib76]), a lacertid lizard that shares a common ancestor with scincid lizards (including *Chalcides*) ∼175 Ma ([@bib12], [@bib13]), and mammals, suggests that uterine IL1 expression is evolutionarily conserved. Although we do not detect IL1 expression, we nonetheless find extensive regulation of other genes that regulate the inflammatory response. The anti-inflammatory cytokine IL11 ([@bib113]) is upregulated, whereas the proinflammatory IL8 and IL15 ([@bib113]; [@bib17]) are significantly downregulated. Finally, the proinflammatory cytokine high-mobility group box 1 (HMGB1) is significantly downregulated.

Significant upregulation and downregulation of other immune system genes also suggest active regulation of the inflammatory response in the uterus. There is significant downregulation of complement component 3 (C3). C3 plays a key role in activating the immune complement system, a component of the innate immune system that has roles in promoting local inflammation and stimulating a cascade of immune response including elements of the adaptive immune system ([@bib83]; [@bib45]; [@bib105]). Excessive complement activation may lead to inhibited fetal growth or pregnancy termination in mammals ([@bib15]; [@bib35]).

However, not all inflammatory immune response genes are regulated to prevent inflammation in the pregnant *C. ocellatus* uterus. For example, phospholipase A2 IB is highly upregulated (PLA2G1B). PLA2G1B is typically expressed in the pancreas to digest dietary phospholipids in the duodenum, but in mammals, it is also expressed in nonpancreatic tissues where it likely plays a role in promoting inflammation by stimulating arachidonic acid release ([@bib68]). Phospholipase A2 expression is also critical for proper implantation in mammals ([@bib118]). On the other hand, function of PLA2G1B may be mediated by the expression of its receptor ([@bib60]) that is not differentially expressed between the pregnant and nonpregnant uteri (*P* = 0.91; data not shown). Regardless, even if PLAS2G1B expression promotes inflammation, its actions are likely regulated by the highly upregulated annexin A4 (ANXA4), a phospholipase A2 inhibitor.

Major histocompatibility loci encode molecules that present antigens to the host\'s immune system and are a key component in the body\'s recognition of "self" from "nonself." Downregulating MHC expression in the embryonic tissues is therefore one mechanism by which the embryo can hide from the maternal immune system ([@bib59]). However, both MHC Class I and II loci are significantly downregulated in the pregnant *C. ocellatus* uterus (the embryonic tissues were not sampled). Uterine downregulation of MHC Class I expression also occurs in cattle, pigs, and sheep, species with noninvasive epitheliochorial placentae, but in these cases, trophoblast cells merge with those of the uterine epithelia to form binucleate syncytia of embryonic and maternal origin ([@bib28]; [@bib19]; [@bib49]); downregulation of MHC Class I expression may be a mechanism by which the maternal immune system ignores these allograft cells in mammals. However, there is no evidence of syncytia formation in *C. ocellatus* (but they may form in the very late stages in pregnancy in *C. chalcides* \[[@bib114]\] and some *Mabuya* group skinks \[[@bib79]; [@bib102]; [@bib10]\]), and thus, the function of uterine MHC downregulation in *C. ocellatus* remains unclear.

Transport across the Placenta
-----------------------------

A majority of the water, organic and inorganic ions, and nutrients used by the embryo in oviparous and lecithotropic viviparous species is provided as yolk within the ovulated egg. By contrast, there is substantial transport of these molecules from the mother to the embryo via the placenta in lizard species with complex placentation ("placentotrophy") ([@bib100]; [@bib78]; [@bib99]). This resource allocation strategy must therefore involve substantial changes in the expression of molecular transporter genes, and our transcriptomic analysis of *C. ocellatus* reveals upregulation of many such loci. Placentotrophy has not been directly measured in *C. ocellatus*, and the species ovulates larger eggs (10 mm; [@bib24]) with a larger yolk mass than highly placentrophic species such as *C. chalcides* (3 mm; [@bib34]), but light and scanning electron microscopic analysis of placental morphology imply that some placentotrophy occurs in *C. ocellatus* ([@bib24]). Moreover, some placentotrophy has even been documented in primarily lecithotrophic species ([@bib100]; [@bib99]).

Mothers of viviparous species provide much more water to their embryos than oviparous species ([@bib100]). Water transport is facilitated by aquaporins, cell membrane proteins that selectively regulate water transport. Aquaporins (AQP) are upregulated in the pregnant rat uterus ([@bib54]) and indeed, AQP1 and AQP3 are also expressed in the uterus of the highly placentotrophic South American scincid lizard, *Mabuya* sp*.* ([@bib110]). AQP3, AQP5, and AQP11 are upregulated in the pregnant *C. ocellatus* uterus.

The last third of pregnancy in reptiles is particularly crucial for the provision of nutrients and ions such as calcium ([@bib96]; [@bib43]) and sodium ([@bib119]), and most of these ions are transported via transcellular routes ([@bib55]). The upregulation of 136 genes in 35 families of solute carrier proteins (SLCs; a majority not shown in [table 2](#tbl2){ref-type="table"} but see [s](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1)[upplementary i](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1)[nformation 1](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1), [Supplementary Material](http://www.gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evs013/-/DC1) online) in the pregnant *C. ocellatus* uterus demonstrates a significant shift to increased inorganic and organic molecular transport during pregnancy (see "transport" in [fig. 1](#fig1){ref-type="fig"}). These upregulated SLC genes include transporters for inorganic ions (includes Ca^2+^, Cl^−^, CO~3~^2−^, H^+^, HCO~3~^−^, K^+^, Na^+^, and PO~4~^3−^), metals (includes Cu^2+^, Fe^2/3+^, Mg^2+^, and Zn^2+^), and organic molecules, including glucose, amino acids, peptides, fatty acids, and carboxylic acids. The three highest upregulated SLC genes are SLC15A1, an oligopeptide transporter, SLC22A17, an organic cation transporter, and SLC2A3, a glucose transporter, which suggest a great transport of organic molecules by the embryo in late pregnancy---a finding supported by physiological studies of other placentotrophic skinks ([@bib100]; [@bib99]).

![Aggregated GO biological processes for significantly regulated genes in the pregnant and nonpregnant uterine transcriptomes. For group descriptions, see text.](gbeevs013f01_ht){#fig1}

Lipids represent the primary source of nutrition to the developing embryo, and physiological studies have inferred a net uptake of lipids across the placenta in numerous viviparous species with relatively complex placentae ([@bib100]; [@bib90]; [@bib99]). Lipid transport is likely facilitated by upregulated fatty acid packaging and transport gene families in the uterus of pregnant *C. ocellatus*. The primary functions of fatty acid binding proteins are to facilitate intracellular transport of fatty acids ([@bib18]) and are active in the mammalian placenta ([@bib42]). Similarly, FABP genes (FABP1---5, 7) are upregulated in pregnant *C. ocellatus*, with FABP1 and FABP7 showing a log~2~-fold expression change of 15.1 and 12.8, respectively. Apolipoproteins are transporters of fatty acids, cholesterol, and phospholipids, and five apolipoproteins (APOA1, APOA2, APOA4, APOE, and APOM) are significantly upregulated in the pregnant uterus of *C. ocellatus*.

Uterine Metabolism and Possible Histotrophy Mediated by Lysosomes in the Omphaloplacenta
----------------------------------------------------------------------------------------

### Uterine Metabolism

As pregnancy progresses, the energy demands to fuel embryonic growth, placental remodeling, and active transport increase sharply, which is reflected in the pregnant *Chalcides* uterus where genes involved with ATP production are highly upregulated. Most of these genes are associated with carbohydrate metabolism, including genes involved in glycolysis (ALDOA, ALDOB, ALDOC, GAPDH, LDHA, PKM2, PGAM1), the citric acid cycle (MDH1, MDH2), electron transport chain (ATP synthases, cytochromes b and c), gluconeogenesis (PCK2), ketogenesis (HMGCS2), and ATP regeneration (CK). One highly upregulated metabolic gene of particular note is glutamate--ammonia ligase (GLUL, also called glutamine synthetase). Glutamine is critical for the synthesis of nucleic acids and sugars as well as cell growth and differentiation ([@bib86]), and upregulation of GLUL mirrors the pattern in numerous mammal species where glutamine concentrations in the fetal plasma are far higher than those in the maternal circulation (e.g., [@bib111]; [@bib16]; [@bib51]; [@bib56]). Thus, the upregulation of GLUL is probably critical to maintaining both reptilian and mammalian pregnancies. The peroxidases catalase (CAT) and glutathione peroxidases 1, 3--5 (GPX1, GPX3--5) are upregulated in the pregnant *C. ocellatus* uterus. These enzymes function to scavenge reactive oxygen species that are the by-product of oxidative metabolism ([@bib67]) and are thus markers of increased uterine metabolic activity during pregnancy.

No study has inferred the precise mechanism by which carbon dioxide produced by the embryo is eliminated by the mother, yet the upregulation of carbonic anhydrase II (CA2) offers an intriguing potential mechanism ([@bib93]). Carbonic anhydrase II catalyzes the reversible reaction of converting CO~2~ and H~2~O to HCO~3~^−^ and H^+^. In oviparous amniotes, expression of CA2 in the chorioallantois promotes acidification of the eggshell to release calcium carbonate for absorption by the embryo ([@bib95]). Thus, the significant upregulation of this gene in the viviparous *C. ocellatus* uterus suggests that it may play a different role during pregnancy. We hypothesize that CA2 has been co-opted into the role of eliminating CO~2~ produced by the embryo in viviparous squamates.

### Histotrophy

Viviparous squamate reptiles with complex placentae experience a net uptake of macromolecules during pregnancy (especially lipids; [@bib99]). Thus, these species must have the catabolic machinery to digest lipid and protein macromolecules into smaller units that can be actively transported to the embryo via the placenta. Microscopic examination and alkaline phosphatase assays suggest that catabolism and transport of macromolecules occur in the omphaloplacenta (also called the "yolk sac" placenta) of placentrophic lizards ([@bib24]; [@bib1]; [@bib99]; [@bib6]). The omphaloplacenta lies at the abembryonic pole of the embryo/yolk mass and typically consists of well-developed columnar epithelial tissue usually associated with secretory epithelia ([@bib24]; [@bib1]; [@bib99]). An extensive array of electron dense structures, interpreted to be lysosomes, occur in the omphaloplacenta of two viviparous *Pseudemoia* skinks ([@bib6]) and in *C. ocellatus* ([@bib24], fig. 3*B* in that paper). Although many of the nutrients transported across the placenta to the embryo may derive from the mother\'s digestive system, the massive upregulation of lysosomal proteases (e.g., cathepsins, LGMN, TPP1) supports the morphological interpretation that histotrophic activity occurs in the omphaloplacenta. We also detected upregulation of lysosomal hydrolases, including hexosaminidases, fucosidases, galactosidases, and sialidase ([table 2](#tbl2){ref-type="table"}). Lysosomal hydrolases break down the glycosidic bonds of glycolipids and glycoproteins and frequently process macromolecules digested by proteolytic enzymes ([@bib109]). The putative presence of lysosomes and the upregulation of lysosomal genes collectively suggest that the omphaloplacenta plays a key role in placentotrophy in *C. ocellatus* but testing this hypothesis will require studies of tissue and cell-specific expression of these genes.

Steroid Hormones
----------------

Concentrations of circulating estrogen and progesterone during gestation are extremely varied across both oviparous and viviparous reptile species ([@bib36]; [@bib64]). In *C. ocellatus*, we found significant downregulation of progesterone (PGR) receptor and estrogen receptor 1 (ESR1) (log~2~-fold change = −3.1 and −4.0, respectively). This finding is puzzling because in *C. chalcides*, blood serum progesterone concentrations increase over the course of pregnancy with the highest concentration before birth ([@bib39]). We did not measure serum levels of progesterone in *C. ocellatus* and thus cannot determine whether the downregulated activity of PGR corresponds to a lower concentration of the hormone during late pregnancy or whether PGR downregulation is a mechanism of functional progesterone withdrawal.

Although serum estrogen has not been measured during pregnancy in any *Chalcides* species, concentrations of circulating estradiol rise during vitellogenesis, peak at the periovulation stage, and then decrease to previtellogenesis concentrations in late pregnancy in the distantly related skink *Niveoscincus metallicus* ([@bib47]). Thus, low ESR1 expression in the pregnant *C. ocellatus* uterus is not wholly unexpected. The absence or downregulation of PGR and ESR1 in the uterine epithelia is not unprecedented. In mammals, implantation is preceded by a loss of PGR and ESR1 expression in the uterine epithelia ([@bib91]; [@bib92]; [@bib3]), and expression in the luminal epithelium and superficial glandular epithelium of PGR and ESR1 is also absent through most of sheep and pig pregnancy, but PR is expressed in endometrial stroma ([@bib116]; [@bib91]). Mammalian uterine epithelia proliferate in response to progesterone and estrogen, but the actions of these hormones are mediated by paracrine signaling from endometrial stromal cells that do exhibit PGR and ESR1 expression (see [@bib3] for review; [@bib22]). However, this mammalian model of stromal cell--mediated effects of progesterone and estrogen may not be applicable to *C. ocellatus* because our pregnant uterus sample contained stromal tissue, yet PGR and ESR1 expression were downregulated. Sustained PGR and ESR expression also occur in the myometrium of mice and sheep ([@bib91]), but this too appears to differ with *C. ocellatus* given that our tissue sample contained both myometrium and endometrium. In summary, PGR and ESR expression are extremely low in the uterine epithelia of mammals and in the entire uterus of *C. ocellatus*, but the mechanism that explains this phenomenon, whether low progesterone and estrogen levels or some other compensatory mechanism, remains unknown.

Conclusion
==========

This study is the first successful use of RNA-Seq methods to characterize changes in pregnancy-associated gene expression in any squamate reptile and a significant step toward uncovering the genetic mechanisms behind the evolution of viviparity in reptiles. Our results serve as a baseline for future comparative gene expression analyses. *Chalcides* represents only one of the 100+ origins of viviparity in squamate reptiles, so we are not able assess the generality of our gene expression results. Nonetheless, there are clear parallels between the genetic processes associated with pregnancy in mammals and *Chalcides* in terms of gene expression related to tissue remodeling, angiogenesis, immune system regulation, and nutrient provisioning to the embryo. Although estrogen and progesterone receptors are downregulated in mammalian uterine epithelia, downregulation of these genes in the entire *C. ocellatus* uterus is evidence that the gene expression profiles of pregnant mammalian and reptilian uteri are not identical. Future RNA-Seq analyses of other viviparous and oviparous squamate reptiles will reveal the extent to which our results represent the generality of genetic processes associated with pregnancy in mammals and reptiles and potentially explain why the transition to viviparity is so easy in squamates. Moreover, future studies should localize the expression of highly regulated genes in both maternal and embryonic tissues.
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